Ibalizumab-uiyk (Trogarzo) for Multidrug-Resistant HIV

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2018年 / 60卷 / 1545期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [1] 美国FDA批准Trogarzo(ibalizumab-uiyk)用于治疗HIV感染
    夏训明
    广东药科大学学报, 2018, 34 (02) : 253 - 253
  • [2] FDA批准中裕新药Trogarzo(ibalizumab-uiyk)上市用于治疗成人HIV感染
    临床合理用药杂志, 2018, (08) : 119 - 119
  • [3] The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States
    Brogan, Anita J.
    Talbird, Sandra E.
    Davis, Ashley E.
    La, Elizabeth M.
    Kumar, Princy N.
    PHARMACOECONOMICS, 2021, 39 (04) : 421 - 432
  • [4] The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States
    Anita J. Brogan
    Sandra E. Talbird
    Ashley E. Davis
    Elizabeth M. La
    Princy N. Kumar
    PharmacoEconomics, 2021, 39 : 421 - 432
  • [5] FDA批准抗HIV药Ibalizumab-uiyk上市
    中国合理用药探索, 2018, (03) : 75 - 75
  • [6] Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty
    Sheikh, Virginia
    Murray, Jeffrey S.
    Sherwat, Adam
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07) : 605 - 607
  • [7] Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
    Rizza, S. A.
    Bhatia, R.
    Zeuli, J.
    Temesgen, Z.
    DRUGS OF TODAY, 2019, 55 (01) : 25 - 34
  • [8] Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
    Blair, Hannah A.
    DRUGS, 2020, 80 (02) : 189 - 196
  • [9] Ibalizumab-uiyk as a bridge therapy for a patient with drug-resistant HIV-1 infection receiving chemotherapy: A case report
    Dickter, Jana K.
    Martin, Abigail L.
    Ho, Stephanie
    Ross, Justine A.
    Shouse, Geoffrey P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (04) : 1185 - 1187
  • [10] Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
    Hannah A. Blair
    Drugs, 2020, 80 : 189 - 196
12345